Effect of scopoletin on lipoprotein lipase activity in 3T3-L1 adipocytes

International Journal of Molecular Medicine

Volumn 20, Issue 4, 2007, Pages 527-531

  Yang, Jeong Yeh ^a   Koo, Jeung Hyun ^a   Yoon, Ha Yong ^a   Lee, Ju Hyung ^a   Park, Byung Hyun ^a   Kim, Jong Suk ^a   Chi, Myung S ^a,b   Park, Jin Woo ^a  

^a Chonbuk National University   (South Korea)

^b LINCOLN UNIVERSITY   (United States)

Author keywords

Adipocyte; Lipoprotein lipase; Scopoletin

Indexed keywords

HEPARIN; LIPOPROTEIN LIPASE; MESSENGER RNA; SCOPOLETIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; TIME;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPARIN; LIPOPROTEIN LIPASE; MICE; RNA, MESSENGER; SCOPOLETIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 38049126070     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.4.527     Document Type: Article

References (33)

1. Yuan G, Al-Shali KZ and Hegele RA: Hypertriglyceridemia: its etiology, effects and treatment. Can Med Assoc J 176: 1113-1120, 2007. (Pubitemid 46649735)
2. Rapp RJ: Hypertriglyceridemia: a review beyond low-density lipoprotein. Cardiol Rev 10: 163-172, 2002.
3. Gan SI, Edwards AL, Symonds CJ and Beck PL: Hypertriglyceridemia-induced pancreatitis: A case-based review. World J Gastroenterol 12: 7197-7202, 2006.
4. Stein Y and Stein O: Lipoprotein lipase and atherosclerosis. Atherosclerosis 170: 1-9, 2003.
5. Blanchette-Mackie EJ, Masuno H, Dwyer NK, Olivecrona T and Scow RO: Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol 256: E818-E828, 1989.
6. Masuno H, Schultz CJ, Park JW, Blanchette-Mackie EJ, Mateo C and Scow RO: Glycosylation, activity and secretion of lipoprotein lipase in cultured brown adipocytes of newborn mice. Effect of tunicamycin, monensin, 1-deoxymannojirimycin and swainsonine. Biochem J 277: 801-809, 1991.
7. Park JW, Oh MS, Yang JY, et al: Glycosylation, dimerization, and heparin affinity of lipoprotein lipase in 3T3-L1 adipocytes. Biochim Biophys Acta 1254: 45-50, 1995.
8. Berryman DE and Bensadoun A: Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells. J Biol Chem 270: 24525-24531, 1995.
9. Enerback S and Gimble JM: Lipoprotein lipase gene expression: physiological regulators at the transcriptional and post-transcriptional level. Biochim Biophys Acta 1169: 107-125, 1993. (Pubitemid 23234587)
10. Mead JR, Irvine SA and Ramji DP: Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80: 753-769, 2002.
11. Bjorntorp P: The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 20: 291-302, 1996. (Pubitemid 26110403)
12. Semenkovich CF, Wims M, Noe L, Etienne J and Chan L: Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem 264: 9030-9038, 1989. (Pubitemid 19151633)
13. Kang SY, Sung SH, Park JH and Kim YC: Hepatoprotective activity of scopoletin, a constituent of Solanum lyratum. Arch Pharm Res 21: 718-722, 1998.
14. Shaw CY, Chen CH, Hsu CC, Chen CC and Tsai YC: Antioxidant properties of scopoletin isolated from Sinomonium acutum. Phytother Res 17: 823-825, 2003.
15. Oliveira EJ, Romero MA, Silva MS, Silva BA and Medeiros IA: Intracellular calcium mobilization as a target for the spasmolytic action of scopoletin. Planta Med 67: 605-608, 2001.
16. Kang TH, Pae HO, Jeong SJ, et al: Scopoletin: an inducible nitric oxide synthesis inhibitory active constituent from Artemisia feddei. Planta Med 65: 400-403, 1999.
17. Kim EK, Kwon KB, Shin BC, et al: Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor κB and caspase-3. Life Sci 77: 824-836, 2005.
18. Hara T, Cameron-Smith D, Cooney GJ, Kusunoki M, Tsutsumi K and Storlien LH: The actions of a novel lipoprotein lipase activator, NO-1886, in hypertriglyceridemic fructose-fed rats. Metabolism 47: 149-153, 1998.
19. Ohara M, Tsutsumi K and Ohsawa N: Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator. Metabolism 47: 101-105, 1998.
20. Lee JH, Kim KA, Kwon KB, et al: Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells. Int J Mol Med 20: 59-64, 2007.
21. Park JW, Lee SY, Yang JY, et al: Effect of carbonyl cyanide m-chlorophenylhydrazone (CCCP) on the dimerization of lipoprotein lipase. Biochim Biophys Acta 1344: 132-138, 1997.
22. Nilsson-Ehle P and Schotz MC: A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J Lipid Res 17: 536-541, 1976.
23. Feingold KR, Marshall M, Gulli R, Moser AH and Grunfeld C: Effect of endotoxin and cytokines on lipoprotein lipase activity in mice. Arterioscler Thromb 14: 1866-1872, 1994.
24. Olivecrona T, Chernick SS, Bengtsson-Olivecrona G, Garrison M and Scow RO: Synthesis and secretion of lipoprotein lipase in 3T3-L1 adipocytes; Demonstration of inactive forms of lipase in cells. J Biol Chem 262: 10748-10759, 1987.
25. Lanza-Jacoby S, Phetteplace H, Sedkova N and Knee G: Sequential alterations in tissue lipoprotein lipase, triglyceride secretion rates, and serum tumor necrosis factor α during Escherichia coli bacteremic sepsis in relation to the development of hypertriglyceridemia. Shock 9: 46-51, 1998.
26. Semb H, Peterson J, Tavernier J and Olivecrona T: Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 262: 8390-8394, 1987.
27. Mackay AG, Oliver JD and Rogers MP: Regulation of lipoprotein lipase activity and mRNA content in rat epididymal adipose tissue in vitro by recombinant tumour necrosis factor. Biochem J 269: 123-126, 1990.
28. Mahley RW and Bersot TP: Drug therapy for hypercholesterolemia and dyslipidemia. In: Goodman and Gilman's The Pharmacological Basis of Therapeutics. Hardman JG, Limberd LE and G. GA (eds). McGraw-Hill, New York, pp971-1002, 2001.
29. Yin W and Tsutsumi K: Lipoprotein lipase activator NO-1886. Cardiovasc Drug Rev 21: 133-142, 2003.
30. Yin W, Yuan Z, Tsutsumi K, et al: A lipoprotein lipase-promoting agent, NO-1886, improves glucose and lipid metabolism in high fat, high sucrose-fed New Zealand white rabbits. Int J Exp Diabesity Res 4: 27-34, 2003.
31. Yin W, Tsutsumi K, Yuan Z and Yang B: Effects of the lipoprotein lipase activator NO-1886 as a suppressor agent of atherosclerosis in aorta of mild diabetic rabbits. Arzneimittel-Forschung 52: 610-614, 2002.
32. Bensadoun A: Lipoprotein lipase. Annu Rev Nutr 11: 217-237, 1991.
33. Mead JR and Ramji DP: The pivotal role of lipoprotein lipase in atherosclerosis. Cardiovasc Res 55: 261-269, 2002.